Skip to main navigation Skip to search Skip to main content

sEcad as a Novel Target and Therapy for IGF-1R Expressing Tumors

Project: Research

Project Details

StatusFinished
Effective start/end date12/1/20 → 12/31/25

Funding

  • National Cancer Institute: $904,930.50